Q32 Bio appoints José Trevejo as chief medical officer, coming from Enveda Therapeutics
STAT+ ran its regular "up and down the ladder" column highlighting recent personnel moves in the pharma sector. The feature invites readers to share hiring, promotion and departure news for broader distribution.
In this edition, Q32 Bio announced the hiring of José Trevejo as its new chief medical officer. Trevejo previously served as chief medical officer and head of clinical pipeline strategy at Enveda Therapeutics, bringing extensive experience in drug development.
The column reminds industry professionals that they can submit their own staffing updates, helping keep the community informed about key talent shifts across companies.
This writeup was produced by pharmadog from original reporting by STAT.
Original headline: “STAT+: Up and down the ladder: The latest comings and goings”
read at STAT ↗
comments(0)
5-min edit window · permanent after that